John A. Libertino

10.2k total citations
184 papers, 4.7k citations indexed

About

John A. Libertino is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, John A. Libertino has authored 184 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 80 papers in Surgery and 36 papers in Molecular Biology. Recurrent topics in John A. Libertino's work include Renal and Vascular Pathologies (44 papers), Renal cell carcinoma treatment (41 papers) and Bladder and Urothelial Cancer Treatments (37 papers). John A. Libertino is often cited by papers focused on Renal and Vascular Pathologies (44 papers), Renal cell carcinoma treatment (41 papers) and Bladder and Urothelial Cancer Treatments (37 papers). John A. Libertino collaborates with scholars based in United States, Italy and Brazil. John A. Libertino's co-authors include Leonard Zinman, Ian C. Summerhayes, Alireza Moinzadeh, Kimberly Rieger‐Christ, Matthew Wszolek, Patrick A. Kenney, Chad Wotkowicz, Mark L. Silverman, Elton Watkins and Brasil Silva Neto and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

John A. Libertino

173 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Libertino United States 40 2.4k 1.8k 1.5k 638 518 184 4.7k
Dragan Golijanin United States 33 1.5k 0.6× 1.5k 0.8× 1.2k 0.8× 614 1.0× 628 1.2× 110 4.0k
Dov Pode Israel 35 1.4k 0.6× 1.7k 1.0× 1.2k 0.8× 514 0.8× 471 0.9× 162 4.3k
Amnon Zisman Israel 41 4.9k 2.0× 1.8k 1.0× 3.3k 2.2× 1.5k 2.4× 1.0k 2.0× 173 6.4k
C.C. Abbou France 40 2.5k 1.1× 2.3k 1.3× 2.0k 1.3× 684 1.1× 678 1.3× 139 5.0k
Thomas E. Keane United States 33 2.5k 1.0× 1.3k 0.7× 1.8k 1.2× 402 0.6× 718 1.4× 126 4.3k
In Gab Jeong South Korea 30 2.1k 0.9× 1.3k 0.7× 880 0.6× 351 0.6× 443 0.9× 234 3.6k
Francis J. McGovern United States 29 4.4k 1.8× 1.4k 0.8× 2.6k 1.7× 792 1.2× 1.6k 3.0× 90 6.5k
Jun Nakashima Japan 35 1.7k 0.7× 1.0k 0.6× 800 0.5× 638 1.0× 1.1k 2.0× 173 4.1k
Giuseppe Simone Italy 36 2.0k 0.8× 2.2k 1.2× 838 0.5× 241 0.4× 386 0.7× 239 4.1k
Ofer Yossepowitch Israel 35 3.4k 1.4× 1.8k 1.0× 787 0.5× 410 0.6× 608 1.2× 164 5.0k

Countries citing papers authored by John A. Libertino

Since Specialization
Citations

This map shows the geographic impact of John A. Libertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Libertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Libertino more than expected).

Fields of papers citing papers by John A. Libertino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Libertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Libertino. The network helps show where John A. Libertino may publish in the future.

Co-authorship network of co-authors of John A. Libertino

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Libertino. A scholar is included among the top collaborators of John A. Libertino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Libertino. John A. Libertino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marra, Giancarlo, Paolo Gontero, Claudia Filippini, et al.. (2018). Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. Urologic Oncology Seminars and Original Investigations. 36(7). 339.e1–339.e8. 5 indexed citations
2.
Kowalik, Casey G., Travis Sullivan, John M. Dugan, et al.. (2017). Profiling micro RNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma. British Journal of Urology. 120(3). 428–440. 28 indexed citations
3.
Sullivan, Travis, John G. Humphrey, Tanya Logvinenko, et al.. (2015). A non-invasive miRNA based assay to detect bladder cancer in cell-free urine.. PubMed. 7(11). 2500–9. 83 indexed citations
4.
Kozinn, Spencer, Niall Harty, Jessica DeLong, et al.. (2013). MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines. Genes & Cancer. 4(1-2). 61–69. 35 indexed citations
5.
Prinz, Richard A., S. Dennis, Beth A. Ryder, et al.. (2008). Incidental Findings at Surgery—Part 2. Current Problems in Surgery. 45(6). 388–439. 2 indexed citations
6.
Cohen, Michael S., Joshua M. Stern, Alex J. Vanni, et al.. (2007). In Vitro Analysis of a Nanocrystalline Silver-Coated Surgical Mesh. Surgical Infections. 8(3). 397–404. 144 indexed citations
7.
8.
Chung, Benjamin I., Karim Hamawy, Leonard N. Zinman, & John A. Libertino. (2006). The Use of Bowel for Ureteral Replacement for Complex Ureteral Reconstruction. The Journal of Urology. 175(1). 179???184–179???184.
9.
Chiang, George, David Canes, John T. Stoffel, et al.. (2005). The src‐family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt. British Journal of Urology. 96(3). 416–422. 19 indexed citations
10.
Chung, Benjamin I., et al.. (2003). Expression of the Proto-Oncogene Axl in Renal Cell Carcinoma. DNA and Cell Biology. 22(8). 533–540. 59 indexed citations
11.
Huang, William C., et al.. (2002). KIAA1096, a Gene on Chromosome 1q, is Amplified and Overexpressed in Bladder Cancer. DNA and Cell Biology. 21(10). 707–715. 15 indexed citations
12.
Wang, David S., Kimberly Rieger‐Christ, Jerilyn M. Latini, et al.. (2000). Molecular analysis ofPTEN andMXI1 in primary bladder carcinoma. International Journal of Cancer. 88(4). 620–625. 56 indexed citations
13.
Sorcini, Andrea & John A. Libertino. (1999). Vascular reconstruction in urology. Urologic Clinics of North America. 26(1). 219–234. 17 indexed citations
14.
Libertino, John A., et al.. (1992). Is magnetic resonance imaging alone accurate enough in staging renal cell carcinoma?. Urology. 40(4). 351–353. 7 indexed citations
15.
Libertino, John A.. (1987). Pediatric and adult reconstructive urologic surgery. Williams & Wilkins eBooks. 9 indexed citations
16.
Rossi, Ricardo L., John A. Libertino, Joseph B. Dowd, & John W. Braasch. (1979). Neurocutaneous syndromes and retroperitoneal tumors. Urology. 13(3). 292–294. 5 indexed citations
17.
D’Elia, John A., Larry A. Weinrauch, Robert W. Healy, et al.. (1979). Myocardial dysfunction without coronary artery disease in diabetic renal failure. The American Journal of Cardiology. 43(2). 193–199. 55 indexed citations
18.
Derhagopian, Robert P., et al.. (1974). Vascular injury of cadaver kidney. Urology. 3(1). 15–17. 1 indexed citations
19.
Libertino, John A. & Leonard Zinman. (1973). Technique for Ureteroneocystostomy in Renal Transplantation and Reflux. Surgical Clinics of North America. 53(2). 459–463. 4 indexed citations
20.
Zinman, Leonard & John A. Libertino. (1973). Surgical Management of Urethral Strictures. Surgical Clinics of North America. 53(2). 465–472.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dragan Golijanin Breakdown of academic impact, for papers by Dov Pode Breakdown of academic impact, for papers by Amnon Zisman Breakdown of academic impact, for papers by C.C. Abbou Breakdown of academic impact, for papers by Thomas E. Keane Breakdown of academic impact, for papers by In Gab Jeong Breakdown of academic impact, for papers by Francis J. McGovern Breakdown of academic impact, for papers by Jun Nakashima Breakdown of academic impact, for papers by Giuseppe Simone Breakdown of academic impact, for papers by Ofer Yossepowitch
Rankless by CCL
2026